
Avoid manufacturing failures by effective viral inactivation.
Chief Scientific Officer at BioReliance UK
Avoid manufacturing failures by effective viral inactivation.
Published: October 1st 2008 | Updated:
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.